[HTML][HTML] Achieving clinical success with BET inhibitors as anti-cancer agents
T Shorstova, WD Foulkes, M Witcher - British journal of cancer, 2021 - nature.com
The transcriptional upregulation of oncogenes is a driving force behind the progression of
many tumours. However, until a decade ago, the concept of 'switching off'these oncogenic …
many tumours. However, until a decade ago, the concept of 'switching off'these oncogenic …
The SWI/SNF complex in cancer—biology, biomarkers and therapy
P Mittal, CWM Roberts - Nature reviews Clinical oncology, 2020 - nature.com
Cancer genome-sequencing studies have revealed a remarkably high prevalence of
mutations in genes encoding subunits of the SWI/SNF chromatin-remodelling complexes …
mutations in genes encoding subunits of the SWI/SNF chromatin-remodelling complexes …
[HTML][HTML] Squamous cell lung cancer: Current landscape and future therapeutic options
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with
high mortality and a lack of therapies specific to this disease. Although recurrent molecular …
high mortality and a lack of therapies specific to this disease. Although recurrent molecular …
SMARCA4: Implications of an Altered Chromatin-Remodeling Gene for Cancer Development and Therapy
K Mardinian, JJ Adashek, GP Botta, S Kato… - Molecular cancer …, 2021 - AACR
The SWI/SNF chromatin remodeling complex, via nucleosome topology modulation,
regulates transcription. The SMARCA4 (BRG1) subunit codes for the ATPase energy engine …
regulates transcription. The SMARCA4 (BRG1) subunit codes for the ATPase energy engine …
[HTML][HTML] Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Multi-subunit ATPase-dependent chromatin remodelling complexes SWI/SNF
(switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene …
(switch/sucrose non-fermentable) are fundamental epigenetic regulators of gene …
Small-cell carcinoma of the ovary, hypercalcemic type–genetics, new treatment targets, and current management guidelines
Small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and highly
aggressive ovarian malignancy. In almost all cases, it is associated with somatic and often …
aggressive ovarian malignancy. In almost all cases, it is associated with somatic and often …
Recent updates in thoracic SMARCA4-deficient undifferentiated tumor
A Nambirajan, D Jain - Seminars in Diagnostic Pathology, 2021 - Elsevier
Germline inactivating mutations in SMARCA4 (SWI/SNF-related, matrix-associated, actin-
dependent regulator of chromatin, subfamily A, member 4) gene encoding for BRG1 …
dependent regulator of chromatin, subfamily A, member 4) gene encoding for BRG1 …
[HTML][HTML] Ovarian cancer: epigenetics, drug resistance, and progression
W Xie, H Sun, X Li, F Lin, Z Wang, X Wang - Cancer cell international, 2021 - Springer
Ovarian cancer (OC) is one of the most common malignant tumors in women. OC is
associated with the activation of oncogenes, the inactivation of tumor suppressor genes, and …
associated with the activation of oncogenes, the inactivation of tumor suppressor genes, and …
[HTML][HTML] Clinicopathologic characteristics of BRG1-deficient NSCLC
I Dagogo-Jack, AB Schrock, M Kem, N Jessop… - Journal of Thoracic …, 2020 - Elsevier
Abstract Introduction Ten percent of NSCLCs harbor mutations in SMARCA4, the gene
encoding the SWItch/Sucrose Non-Fermentable ATPase BRG1. In preclinical models, BRG1 …
encoding the SWItch/Sucrose Non-Fermentable ATPase BRG1. In preclinical models, BRG1 …
Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors
K Chatzopoulos, JM Boland - Virchows Archiv, 2021 - Springer
NUT carcinoma, also known as NUT midline carcinoma, is an aggressive malignancy mainly
affecting the midline structures of younger patients and almost invariably leading to death …
affecting the midline structures of younger patients and almost invariably leading to death …